Just read this article on Novartis' acquisition of IFM Tre....happened last May and included $310M upfront with potential for milestone payments of $1.25B. The company had one Phase I trial ongoing and a few pre-clinicals. Hmmmm........

https://www.prnewswire.com/news-releases/ifm-...45798.html